Floatz logo

Synthetic Human Papillomavirus 16 E6 Peptide

Penile Cancer

National Cancer Institute (NCI)protein_peptidePhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

17 Active assets in the Penile Cancer cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Christian Hinrichs
Phase 2BB
Fludarabine
Christian Hinrichs
Phase 2BB
Bms-907351
National Cancer Institute (NCI)
Phase 2B
9-valent human papillomavirus recombinant vaccine
Shanghai Bovax Biotechnology Co., Ltd.
Phase 3B
e7 tcr-t cells
Christian Hinrichs
Phase 2B

View all 28 →

Same molecule, other indications

Synthetic Human Papillomavirus 16 E6 Peptide is also rated in:

vulva cancerDormant
CC
Indicative ·
46 / 100
View asset →
anal carcinomaDormant
CC
Indicative ·
42 / 100
View asset →
head and neck cancerDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →